AbbVie Market Cap 2010-2019 | ABBV

AbbVie market cap history and chart from 2010 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AbbVie market cap as of January 23, 2020 is $126.1B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $126.099B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.912B 17.11
Roche Holding AG (RHHBY) Switzerland $290.307B 0.00
Merck (MRK) United States $225.472B 17.47
Pfizer (PFE) United States $225.294B 13.39
Novartis AG (NVS) Switzerland $217.538B 18.36
Novo Nordisk (NVO) Denmark $145.845B 25.14
Eli Lilly (LLY) United States $135.580B 25.04
AstraZeneca (AZN) United Kingdom $131.713B 23.79
Sanofi (SNY) France $124.205B 15.26
GlaxoSmithKline (GSK) United Kingdom $119.273B 14.45
Bristol-Myers Squibb (BMY) United States $108.950B 15.23
Bayer (BAYRY) Germany $80.535B 11.93
H Lundbeck (HLUYY) Denmark $8.089B 14.06